The timeframe for Class I medical device registration with China's National Medical Products Administration (NMPA) can vary based on several factors, including the completeness of the application, the complexity of the device, and current regulatory workload. Generally, the process can be outlined with the following considerations:

1. Preparation Phase: This involves gathering all necessary documentation, preparing technical files, and ensuring compliance with Chinese regulatory requirements. The duration of this phase depends on how quickly the required documentation can be assembled and organized.

2. Submission and Administrative Review: Once the application is submitted to the NMPA, there is an initial administrative review phase. This typically involves checking the completeness of the application and ensuring all required documents are included. This phase can take a few weeks to a couple of months, depending on the workload of the NMPA and the complexity of the application.

3. Technical Review and Evaluation: After passing the administrative review, the NMPA conducts a technical review to evaluate the device's safety, efficacy, and quality based on the submitted documentation. This phase may also involve additional testing or evaluations depending on the device type. The duration of this phase can vary significantly depending on the complexity of the device and any specific regulatory requirements.

4. Decision and Approval: Once the NMPA is satisfied with the technical documentation and compliance of the device, they issue a registration certificate. This is the official approval that allows the device to be marketed and sold in China. The timeframe for receiving this approval can range from several months to over a year, again depending on various factors including the completeness of the application and regulatory workload.

Factors Affecting Timeframe:

• Documentation Completeness: Ensuring all required documentation is accurate, complete, and well-organized can expedite the review process.
• Regulatory Changes: Any updates or changes in Chinese regulatory requirements may impact the timeline as manufacturers may need to adjust their submissions accordingly.
• Communication and Coordination: Effective communication with the NMPA and local agents, as well as prompt responses to requests for additional information, can help prevent delays.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn